Generated Narrative: Composition composition-en-822aeee7cf35efce0583ec39919328fb Language: en Profile: Composition (ePI) identifier: https://spor.ema.europa.eu/rmswi//70d297fbf8cb6fb1fb345ef62d74745f status: Final type: Package Leaflet category: Raw date: 2022-02-16 13:28:17+0000 author: Organization AstraZeneca AB title: TEST PURPOSES ONLY - Fluenz Tetra nasal spray suspension Attesters - Mode Time * Official 2022-02-16 13:28:17+0000
TEST PURPOSES ONLY - Fluenz Tetra nasal spray suspension
unavailable
Package leaflet: Information for the user
Read all of this leaflet carefully before the vaccine is given because it contains important information for you or your child. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, nurse or pharmacist. This vaccine has been prescribed for you or your child only. Do not pass it on to others. If any of the side effects gets serious, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet: What Fluenz Tetra is and what it is used for What you need to know before you are given Fluenz Tetra How Fluenz Tetra is given Possible side effects How to store Fluenz Tetra Contents of the pack and other information
Fluenz Tetra is a vaccine to prevent influenza (flu). It is used in children and adolescents 24 months to less than 18 years of age. Fluenz Tetra will help to protect against the four virus strains contained in the vaccine, and other strains closely related to them. How Fluenz Tetra works When a person is given the vaccine, the immune system (the body’s natural defence system) will produce its own protection against the influenza virus. None of the ingredients in the vaccine can cause the flu. Fluenz Tetra vaccine viruses are grown in chicken eggs. Each year the vaccine targets four strains of influenza, following the annual recommendations by the World Health Organisation.
2. What you need to know before you take 0
You will not be given Fluenz Tetra: if you are allergic to gentamicin, gelatin or any of the other ingredients of this vaccine (listed in section 6 “Contents of the pack and other information”). if you have ever had a severe allergic reaction to eggs or egg proteins. For signs of allergic reactions, see section 4 “Possible side effects”. if you have a blood disorder or a cancer that affects the immune system. if you have been told by your doctor that you have a weakened immune system as a result of a disease, medicine or other treatment. if you are already taking acetylsalicylic acid (a substance present in many medicines used to relieve pain and lower fever). This is because of the risk of a very rare but serious disease (Reye’s syndrome). If any of these apply, tell your doctor, nurse or pharmacist. Warnings and precautions Talk to your doctor, nurse or pharmacist before vaccination: if the child is less than 24 months of age. Children less than 24 months of age should not receive this vaccine because of the risk of side effects. if you have severe asthma or are currently wheezing. if you are in close contact with someone with a severely weakened immune system (for example, a bone marrow transplant patient needing isolation). If any of these apply, tell your doctor, nurse or pharmacist before vaccination. He or she will decide if Fluenz Tetra is suitable for you. Other medicines, other vaccines and Fluenz Tetra Tell your doctor, nurse or pharmacist if the person being vaccinated is taking, has recently taken or might take any other medicines, including medicines that do not require a prescription. Do not give acetylsalicylic acid (a substance present in many medicines used to relieve pain and lower fever) to children for 4 weeks after vaccination with Fluenz Tetra unless your doctor, nurse or pharmacist tells you otherwise. This is because of the risk of Reye’s syndrome, a very rare but serious disease that can affect the brain and liver. It is recommended that Fluenz Tetra is not given at the same time as influenza-specific antiviral medicines, such as oseltamivir and zanamivir. This is because the vaccine may work less effectively. Your doctor, nurse or pharmacist will decide if Fluenz Tetra can be given at the same time as other vaccines. Pregnancy and breast-feeding If you are pregnant, think you may be pregnant, plan to become pregnant soon or are breast-feeding, tell your doctor, nurse or pharmacist before receiving this vaccine. Fluenz Tetra is not recommended for women who are pregnant or are breast-feeding. Driving and using machines Fluenz Tetra has no or negligible influence on the ability to drive and use machines.
Fluenz Tetra will be administered under the supervision of a doctor, nurse or pharmacist. Fluenz Tetra must only be used as a nasal spray. Fluenz Tetra must not be injected. Fluenz Tetra will be given as a spray in each nostril. You can breathe normally while you are given Fluenz Tetra. You do not need to actively inhale or sniff. Dosage The recommended dose for children and adolescents is 0.2 ml Fluenz Tetra, administered as 0.1 ml in each nostril. Children who have not previously had an influenza vaccine will receive a second, follow-up dose after an interval of at least 4 weeks. Follow your doctor, nurse or pharmacist’s instructions about if and when your child should return for the second dose. If you have any further questions on this vaccine, ask your doctor, nurse or pharmacist.
Like all medicines, this vaccine can cause side effects, although not everybody gets them. In clinical studies with the vaccine, most side effects were mild in nature and short term. Ask your doctor, nurse or pharmacist if you want more information about possible side effects from Fluenz Tetra. Some side effects may be serious Very rare(may affect up to 1 in 10,000 people): severe allergic reaction: signs of a severe allergic reaction may include shortness of breath and swelling of the face or tongue. Tell your doctor straight away or seek urgent medical care if you experience any of the effects above. Other possible side effects of Fluenz TetraVery common(may affect more than 1 in 10 people): runny or stuffy nose reduced appetite weakness Common(may affect up to 1 in 10 people): fever muscle aches headache Uncommon(may affect up to 1 in 100 people): rash nose bleed allergic reactions Reporting of side effects If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this vaccine out of the sight and reach of children. Do not use this vaccine after the expiry date which is stated on the applicator label after the letters EXP. Store in a refrigerator (2°C to 8°C). Do not freeze. Keep the nasal applicator in the outer carton in order to protect from light. Before use, the vaccine may be taken out of the refrigerator once for a maximum period of 12 hours at a temperature not above 25°C. If the vaccine has not been used after this 12 hour period, it should be discarded. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Fluenz Tetra contains The active substances are: Reassortant influenza virus (live attenuated) of the following four strains*: A/Victoria/4897/2022 (H1N1)pdm09 - like strain E107.0±0.5 FFU* (A/Norway/31694/2022, MEDI 369815) A/Darwin/9/2021 (H3N2) - like strain E107.0±0.5 FFU* (A/Norway/16606/2021, MEDI 355293) B/Austria/1359417/2021 - like strain E107.0±0.5 FFU* (B/Austria/1359417/2021, MEDI 355292) B/Phuket/3073/2013 - like strain E107.0±0.5 FFU* (B/Phuket/3073/2013, MEDI 306444) .................................................................................................................. per 0.2 ml dose * propagated in fertilised hens' eggs from healthy chicken flocks. produced in VERO cells by reverse genetic technology. This product contains genetically modified organisms (GMOs).* fluorescent focus units. This vaccine complies with the WHO (World Health Organisation) recommendations (Northern Hemisphere) and EU decision for the 2023/2024 season. The other ingredients are sucrose, dipotassium phosphate, potassium dihydrogen phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate and water for injections. What Fluenz Tetra looks like and contents of the pack This vaccine is presented as a nasal spray suspension in a single-use nasal applicator (0.2 ml) in a pack size of 1 and 10. Not all pack sizes may be available in your country. The suspension is colourless to pale yellow, clear to slightly cloudy. Small white particles may be present.
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-avictoria48972022 Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Active substance Codes - Concept * A/Victoria/4897/2022 Strengths - Presentation[x] Basis * 0 FFU (Details: UCUM codeFFU = 'FFU') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-adarwin92021h3n2 Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Active substance Codes - Concept * A/Darwin/9/2021 (H3N2) Strengths - Presentation[x] Basis * 0 FFU (Details: UCUM codeFFU = 'FFU') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-baustria13594172021 Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Active substance Codes - Concept * B/Austria/1359417/2021 Strengths - Presentation[x] Basis * 0 FFU (Details: UCUM codeFFU = 'FFU') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-bphuket30732013 Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Active substance Codes - Concept * B/Phuket/3073/2013 - Strengths - Presentation[x] Basis * 0 FFU (Details: UCUM codeFFU = 'FFU') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-sucrose Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Excipient substance Codes - Concept * Sucrose
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-dipotassiumphosphate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Excipient substance Codes - Concept * Dipotassium phosphate
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-potassiumdihydrogenphosphate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Excipient substance Codes - Concept * Potassium dihydrogen phosphate
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-gelatinporcinetypea Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Excipient substance Codes - Concept * Gelatin (porcine, Type A)
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-argininehydrochloride Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Excipient substance Codes - Concept * Arginine hydrochloride
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-monosodiumglutamatemonohydrate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Excipient substance Codes - Concept * Monosodium glutamate monohydrate
Generated Narrative: Ingredient ingredient-for-vaxigriptetra-waterforinjections Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/nan (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan; status = active; administrableDoseForm = Nasal spray; unitOfPresentation = Spray role: Excipient substance Codes - Concept * Water for injections
Generated Narrative: AdministrableProductDefinition ap-635d47ee543a5a9e15fcd321ee5fe6bb Profile: AdministrableProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/nan status: Active formOf: MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription administrableDoseForm: Nasal spray unitOfPresentation: Spray producedFrom: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray routeOfAdministration code: Nasal use TargetSpecies - Code * Human
Generated Narrative: RegulatedAuthorization authorization635d47ee543a5a9e15fcd321ee5fe6bb0 Profile: RegulatedAuthorization (ePI) identifier: https://spor.ema.europa.eu/pmswi/EU/1/13/887/003 (use: official, ) subject: PackagedProductDefinition Fluenz Tetra nasal spray suspension 1 type: Marketing Authorisation status: Active statusDate: 2015-02-07 13:28:17+0000 holder: Organization AstraZeneca AB
Generated Narrative: RegulatedAuthorization authorization635d47ee543a5a9e15fcd321ee5fe6bb1 Profile: RegulatedAuthorization (ePI) identifier: https://spor.ema.europa.eu/pmswi/EU/1/13/887/004 (use: official, ) subject: PackagedProductDefinition Fluenz Tetra nasal spray suspension 10 type: Marketing Authorisation status: Active statusDate: 2015-02-07 13:28:17+0000 holder: Organization AstraZeneca AB
Generated Narrative: Organization man-05de1a64764c002add42fbfd49b6a38d Profile: Organization (ePI) identifier: https://spor.ema.europa.eu/omswi/ORG-100000789 (use: official, ) active: true type: Manufacturer name: MedImmune, UK Limited Contacts - Address * Plot 6, Renaissance Way, Boulevard Industry Park Liverpool UK(work)
Plot 6, Renaissance Way, Boulevard Industry Park Liverpool UK
Plot 6, Renaissance Way, Boulevard Industry Park
Generated Narrative: Organization mah-46a3afc149c080384b82a9e476e79f76 Profile: Organization (ePI) identifier: https://spor.ema.europa.eu/omswi/ORG-100000789 (use: official, ) active: true type: Marketing authorisation holder name: AstraZeneca AB Contacts - Address * SE-151 85 Södertälje Södertälje SWE(work)
Generated Narrative: PackagedProductDefinition ppd-f22a97fafd26aa7001d9fe6a30afa7b2 Profile: PackagedProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/EU/1/13/887/003 (use: official, ) name: Fluenz Tetra nasal spray suspension 1 type: Chemical Medicinal Product packageFor: MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription status: Active statusDate: 2015-02-07 13:28:17+0000 manufacturer: Organization MedImmune, UK Limited packaging type: Box quantity: 1 material: Cardboard packaging identifier: https://spor.ema.europa.eu/pmswi/123456 type: Nasal applicator quantity: 1 containedItem Items - Reference * ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray
Generated Narrative: PackagedProductDefinition ppd-533038a0a634e664ced4f999f6a95f85 Profile: PackagedProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/EU/1/13/887/004 (use: official, ) name: Fluenz Tetra nasal spray suspension 10 type: Chemical Medicinal Product packageFor: MedicinalProductDefinition: identifier = http://fakesys.com/ids#ft1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription status: Active statusDate: 2015-02-07 13:28:17+0000 manufacturer: Organization MedImmune, UK Limited packaging type: Box quantity: 1 material: Cardboard packaging identifier: https://spor.ema.europa.eu/pmswi/123456 type: Nasal applicator quantity: 10 containedItem Items - Reference * ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#nan (use: official, ); status = active; manufacturedDoseForm = Nasal spray; unitOfPresentation = Spray
Generated Narrative: MedicinalProductDefinition mp822aeee7cf35efce0583ec39919328fb Profile: MedicinalProductDefinition (ePI) identifier: http://fakesys.com/ids/ft1 type: Medicinal Product domain: Human use status: active legalStatusOfSupply: Medicinal product subject to medical prescription name productName: Fluenz Tetra nasal spray suspension type: Full name part part: Fluenz Tetra type: Invented name part part part: Reassortant influenza virus* (live attenuated) of four strains type: Scientific name part part part: type: Strength part part part: Nasal Spray type: Pharmaceutical dose form part Usages - Country Jurisdiction Language * Denmark Denmark English
Medicinal product subject to medical prescription
Reassortant influenza virus* (live attenuated) of four strains
Generated Narrative: ManufacturedItemDefinition mid-635d47ee543a5a9e15fcd321ee5fe6bb Profile: ManufacturedItemDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/nan (use: official, ) status: Active manufacturedDoseForm: Nasal spray unitOfPresentation: Spray manufacturer: Organization MedImmune, UK Limited